Healthrageous, United BioSource And Boehringer Ingelheim Launch SMART Digital Diabetes Study

barbara.lempert BOSTON and INGELHEIM, Germany, July 16, 2013 /PRNewswire/ — Healthrageous, Inc., a digital health management company, and Boehringer Ingelheim, announced today ...

The Last Word: For branding success, rely on your GPS – Gut Positioning System!

chris.truelove I wonder if back in the 1980s, when Jack Trout and Al Ries were popularizing the concept of brand positioning, they had any idea of how complicated their simple idea ...

Internal barriers, not regulations, tend to impede pharma social media adoption

chris.truelove A common notion exists that the pharma industry has not fully utilized social media because of regulatory restrictions; however, a recent study from Weber Shandwick ...

CMI/Compas: Docs relying on multiple devices

chris.truelove Doctors – regardless of specialty – are multi-screen users, relying on multiple devices such as a desktop computer, smartphone, and tablet for both professional ...

Summer conference recap

chris.truelove By Dorothy Wetzel People don’t change when they see the light, they change when they feel the heat. The heat is certainly on in the pharmaceutical industry if the ...

Ad Agency Update – People on the Move, July 2013

chris.truelove • AbelsonTaylorCaitlin K. Fitzgibbons is promoted to senior account executive, AbelsonTaylor (abelsontaylor.com). Ms. Fitzgibbons, formerly an account executive, joined ...

To the Point – July 2013

chris.truelove by Christiane Truelove (chris.truelove@ubm.com) The big news story right now is the Supreme Court striking down DOMA, but pharma marketers are more interested in Paula ...

Tetraphase’s lead antibiotic wins special status at the FDA

John Carroll Tetraphase Pharmaceuticals has snagged a special federal designation for its lead antibiotic in the clinic, putting the biotech in line for some extra incentives–like ...

The social media bomb

chris.truelove By Fabio Gratton When it comes to the topic of pharma’s use of social media, we’ve been having this same conversation for over a decade, with more fervor of course ...

Lundbeck, Otsuka tout improved cognition in mid-stage Alzheimer’s study

John Carroll Lundbeck and Otsuka are quickly ramping up a 3,000-patient Phase III study for an experimental Alzheimer's drug after claiming success in improving cognition among ...

Omthera Stockholders Approve Acquisition by AstraZeneca

barbara.lempert PRINCETON, N.J., July 16, 2013 /PRNewswire/ — The stockholders of Omthera Pharmaceuticals, Inc. (NASDAQ: OMTH) (the “Company”) voted today ...

Europe eyes social media and mobile for data on bad drug reactions

John Carroll Europeans want to tackle one of the boogeymen of social media in pharma–adverse drug event reporting. FierceBiotech News
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS